Skip to content

Effects Of Dry Needling On Sternocleidomastoid Muscle For Pain And Disability In Migraine

The Effects of Triggering Points Dry Needling on Sternocleidomastoid Muscle for Pain and Disability in Migraine

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05285852
Enrollment
60
Registered
2022-03-18
Start date
2021-03-01
Completion date
2022-05-15
Last updated
2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

Dry Needling, Sternocleidomastoid Muscle, Pain, Disability, Randomized Control Trial, Migraine

Brief summary

To determine the effects, sequel of dry needling in migraine by resolving MTrPs in sternocleidomastoid muscle. To determine the possession of dry needling technique to mitigate the frequency, intensity and duration of headache. To determine the effectiveness of dry needling in the disability hindrance in migraine patients.

Detailed description

This is a randomized control study of 60 volunteers with migraine induced by myofacial triggers in sternocleidomastoid muscle. The migraine will be diagnosed by the neurologist and for the evaluation of trigger points and muscle thickness ultrasound will be done. After the diagnostic procedure and complete history evaluation from the selected population 30 subjects will be subjected to dry needling group and 30 others will be kept in the placebo group. All the participants will receive six sessions at the myofascial trigger point area there should be the gap of at least 48 hours between two sessions. As for the assessment details, such as the frequency, intensity and duration of the headaches; the consumption of drugs; the thickness of SCM muscles; the pain pressure threshold and the cervical range motions will be recorded before, immediately following the response, and at the 1-month follow-up

Interventions

OTHERDry Needling

Dry needling technique is maneuvered by different skilled health practitioners aiming to reduce central sensitization, i.e., the hypersensitivity to pain of the central nervous system. It is also apprehended to reduce the local and referred pain, and improve the muscle activation patterns leading to improved range of motion.

Placebo Dry Needling only causes a pricking sensation

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Submitted with a headache diagnosis by a neurologist. * Presence of active Trigger points in the Sternocleidomastoid muscle reproducing the symptoms of migraine. * Active trigger points will be identified if there is muscle sensitivity that has been activated by pressure and reproduces the patient's referred pain and headache. * A jump sign the characteristic behavioral response to compression on a trigger point, will be produced.

Exclusion criteria

* background of neck trauma * cervical radiculopathy * History of head/shoulder surgery * Diagnosis of other unusual headaches/migraines * Phobia of pricking * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale12th WeekA Visual Analogue Scale is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
Bubble Inclinometer12th WeekBubble Inclinometer is a simple to use device for measuring range of motion in patients. The inclinometer can be used to measure range of motion in the neck, the hip, the elbow, the knee, the shoulder, the spine, the ankle, the wrist, and the Metacarpophalangeal joint.
Sternocleidomastoid muscle Ultrasonography12th WeekAn ultrasonograph scan uses high-frequency sound waves to make an image of a person's internal body structures

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026